
Selecta Biosciences, Inc.
CEO
Carsten Brunn
IPO Date
2016-06-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 178,000 |
| $0.00 |
| 4 Jan 2024 | Brunn Carsten | director, officer: President and CEO | A-Award | Acquired | 5,971,000 | $0.66 |
| 4 Jan 2024 | Brunn Carsten | director, officer: President and CEO | A-Award | Acquired | 4,654,100 | $0.00 |
| 4 Jan 2024 | DeSilva Nishan M | director | A-Award | Acquired | 228,000 | $0.66 |
| 4 Jan 2024 | DeSilva Nishan M | director | A-Award | Acquired | 178,000 | $0.00 |
| 4 Jan 2024 | COX CARRIE SMITH | director | A-Award | Acquired | 178,000 | $0.00 |
| 4 Jan 2024 | COX CARRIE SMITH | director | A-Award | Acquired | 248,000 | $0.66 |
| 4 Jan 2024 | SPRINGER TIMOTHY A | director, 10 percent owner: | A-Award | Acquired | 178,000 | $0.00 |
| 4 Jan 2024 | SPRINGER TIMOTHY A | director, 10 percent owner: | A-Award | Acquired | 228,000 | $0.66 |